Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.3750
+0.0050 (1.35%)
Feb 19, 2026, 4:10 PM AEST
Island Pharmaceuticals Revenue
In the fiscal year ending June 30, 2025, Island Pharmaceuticals had annual revenue of 118.91K AUD, down -90.57%. Island Pharmaceuticals had revenue of 22.07K in the half year ending June 30, 2025.
Revenue
118.91K
Revenue Growth
-90.57%
P/S Ratio
917.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
109.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 118.91K | -1.14M | -90.57% |
| Jun 30, 2024 | 1.26M | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EZZ Life Science Holdings | 66.87M |
| Radiopharm Theranostics | 12.51M |
| Recce Pharmaceuticals | 7.51M |
| Actinogen Medical | 5.49M |
| Alterity Therapeutics | 5.44M |
| Imugene | 4.40M |
| Prescient Therapeutics | 4.36M |
| Arovella Therapeutics | 3.44M |